raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:411709

Renal agenesis

Type
Morphological anomaly
Group
Disorder
Inheritance
Autosomal dominant, Autosomal recessive
Age of onset
Antenatal, Neonatal
Status
active

A rare, congenital renal tract malformation characterized by the complete absence of development of one or both kidneys (unilateral or bilateral renal agenesis respectively), accompanied by absent ureter(s).

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enRenal agenesis
frAgénésie rénale
deNierenagenesie
esAgenesia renal
itAgenesia renale
nlRenale agenesieAgenesie van nier
ptAgenesia renal
plAgnezja nerki
csAgeneze ledvinyAgeneze ledvin
ukНиркова агенезія
zh肾发育不全
trBöbrek agenezi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM191830BTNTvalidated
OMIM615721BTNTvalidated
ICD-10Q60.0BTNTspecificvalidated
ICD-10Q60.1BTNTspecificvalidated
ICD-10Q60.2BTNTspecificvalidated
ICD-11LB30.00Especificvalidated
MONDO0018470Evalidated
UMLSC0542519Evalidated
GARD9228Evalidated
MedDRA10064655Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

Children (2):

4

Genes

0 direct · 14 via subtypes

Orphanet records no gene directly on this code.

Recorded by Orphanet on subtypes of this disorder:

GeneSubtypeAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
FGF20ORPHA:1848Renal agenesis, bilateralDisease-causing germline mutation(s) (loss of function) inAssessedHGNC:3677ENSG000000785796055588p22fibroblast growth factor 2022698282[PMID]
GREB1LORPHA:1848Renal agenesis, bilateralDisease-causing germline mutation(s) (loss of function) inAssessedHGNC:31042ENSG0000014144961778218q11.1-q11.2GREB1 like retinoic acid receptor coactivator29100090[PMID]_29100091[PMID]
GREB1LORPHA:93100Renal agenesis, unilateralDisease-causing germline mutation(s) (loss of function) inAssessedHGNC:31042ENSG0000014144961778218q11.1-q11.2GREB1 like retinoic acid receptor coactivator29100090[PMID]_29100091[PMID]
RETORPHA:1848Renal agenesis, bilateralDisease-causing germline mutation(s) (loss of function) inAssessedHGNC:9967ENSG0000016573116476110q11.21ret proto-oncogene18252215[PMID]
WNT9BORPHA:1848Renal agenesis, bilateralDisease-causing germline mutation(s) (loss of function) inAssessedHGNC:12779ENSG0000015895560286417q21.32Wnt family member 9B34145744[PMID]
BMP4ORPHA:93100Renal agenesis, unilateralDisease-causing germline mutation(s) inAssessedHGNC:1071ENSG0000012537811226214q22.2bone morphogenetic protein 421900877[PMID]
DSTYKORPHA:93100Renal agenesis, unilateralDisease-causing germline mutation(s) inAssessedHGNC:29043ENSG000001330596126661q32.1dual serine/threonine and tyrosine protein kinase23862974[PMID]_17273976[PMID]
FRAS1ORPHA:93100Renal agenesis, unilateralDisease-causing germline mutation(s) inAssessedHGNC:19185ENSG000001387596078304q21.21Fraser extracellular matrix complex subunit 121900877[PMID]_24700879[PMID]
FREM1ORPHA:93100Renal agenesis, unilateralDisease-causing germline mutation(s) inAssessedHGNC:23399ENSG000001649466089449p22.3FRAS1 related extracellular matrix 124370773[PMID]_20807610[PMID]
FREM2ORPHA:93100Renal agenesis, unilateralDisease-causing germline mutation(s) inAssessedHGNC:25396ENSG0000015089360894513q13.3FRAS1 related extracellular matrix 221900877[PMID]_24700879[PMID]
GFRA1ORPHA:1848Renal agenesis, bilateralDisease-causing germline mutation(s) inAssessedHGNC:4243ENSG0000015189260149610q25.3GDNF family receptor alpha 134737117[PMID]
ITGA8ORPHA:1848Renal agenesis, bilateralDisease-causing germline mutation(s) inAssessedHGNC:6144ENSG0000007794360406310p13integrin subunit alpha 824439109[PMID]
RETORPHA:93100Renal agenesis, unilateralDisease-causing germline mutation(s) inAssessedHGNC:9967ENSG0000016573116476110q11.21ret proto-oncogene21900877[PMID]_24429398[PMID]
UPK3AORPHA:93100Renal agenesis, unilateralDisease-causing germline mutation(s) inAssessedHGNC:12580ENSG0000010037361155922q13.31uroplakin 3A15888565[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyValidatedORPHANET_24370773[PMID]
Prevalence at birth1-5 / 10 000—WorldwideClass onlyValidated24370773[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

16 annotations · validated 2019-07-01
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0000104Renal agenesis
Frequent (79-30%)
HP:0000122Unilateral renal agenesis
HP:0012300Ureteral agenesis
Occasional (29-5%)
HP:0012873Absent vas deferens
HP:0002023Anal atresia
HP:0010476Aplasia/Hypoplasia of the bladder
HP:0008684Aplasia/hypoplasia of the uterus
HP:0010958Bilateral renal agenesis
HP:0000822Hypertension
HP:0001562Oligohydramnios
HP:0002009Potter facies
HP:0000093Proteinuria
HP:0002089Pulmonary hypoplasia
HP:0000083Renal insufficiency
HP:0001762Talipes equinovarus
HP:0001629Ventricular septal defect

Run the differential on the 1 obligate / very frequent terms

Annotation source: 20984673[PMID]_22698282[PMID]_22698282[PMID]_25053522[PMID]

7

Sources for this card